No such message found

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: HDL from an Alzheimer's disease perspective

Bear as we now know that according to Biogen, aducanumab has failed.

Targeting Beta-amyloid plaque does not seem to be the answer as they hoped. 

 

Koo

Share
New Message
Please login to post a reply